What is Advion?
Advion is a global leader in the development, manufacturing, and support of advanced analytical instruments. Their product portfolio includes high-performance mass spectrometers, innovative chip-based ion sources, and microfluidic flow chemistry systems. The company's core mission is to enhance analytical performance and streamline workflows for life science researchers and related industries. By leveraging deep expertise in mass spectrometry and microfluidics, Advion is committed to delivering quality, flexible, and purpose-built solutions that address complex analytical challenges.
How much funding has Advion raised?
Advion has raised a total of $10.6M across 2 funding rounds:
Private Equity
$9.1M
Private Equity
$1.5M
Private Equity (2011): $9.1M, investors not publicly disclosed
Private Equity (2014): $1.5M led by Cayuga Venture Fund, Aisling Capital, L.L.C., and Skyline Ventures
Key Investors in Advion
Cayuga Venture Fund
Cayuga Venture Fund is a venture capital firm operating within the Venture Capital & Private Equity industry, based in Washington, D.C. The firm typically invests in early-stage companies.
Aisling Capital, L.L.C.
Aisling Capital is a premier investment firm focused on innovative healthcare companies, particularly in biopharmaceutical development and commercialization. They target areas like oncology and neuroscience, aiming to invest in transformative healthcare solutions.
Skyline Ventures
Skyline Ventures is a venture capital firm specializing in product-focused healthcare companies, including therapeutics, medical devices, and life science research technologies. Their team brings significant operational and scientific expertise to their portfolio companies.
What's next for Advion?
The recent strategic investment signals a pivotal moment for Advion, likely positioning the company for accelerated scaling and market penetration. This capital infusion is expected to bolster research and development efforts, potentially leading to the introduction of next-generation analytical technologies. Furthermore, the backing from prominent investors suggests confidence in Advion's long-term vision and its capacity to capture greater market share in the competitive life sciences instrumentation landscape. Strategic partnerships and global expansion initiatives may also be on the horizon as Advion aims to solidify its industry leadership.
See full Advion company page
